Chiropractic spinal manipulative therapy for cervicogenic headache: a single-blinded, placebo, randomized controlled trial

Aleksander Chaibi, Heidi Knackstedt, Peter J Tuchin, Michael Bjørn Russell, Aleksander Chaibi, Heidi Knackstedt, Peter J Tuchin, Michael Bjørn Russell

Abstract

Objective: Cervicogenic headache is a disabling headache where pharmacological management have limited effect. Thus, non-pharmacological management is warranted. Our objective was therefore to investigate the efficacy of chiropractic spinal manipulative therapy versus placebo (sham manipulation) and control (continued usual but non-manual management) for cervicogenic headache in a prospective 3-armed single-blinded, placebo, randomized controlled trial of 17 months' duration.

Results: Nineteen participants were equally randomized into the three groups, and 12 participants completed the randomized controlled trial. Headache frequency improved at all time points in the chiropractic spinal manipulative therapy and the placebo group. Headache index improved in the chiropractic spinal manipulative therapy group at all time points, while it improved at 6 and 12 months' follow-up in the placebo group. The control group remained unchanged during the whole study period. Adverse events were few, mild and transient. Blinding was concealed throughout the RCT. Thus, our results suggest that manual-therapy might be a safe treatment option for participants with cervicogenic headache, but data need to be confirmed in a randomized controlled trial with sufficient sample size and statistical power. Trial registration ClinicalTrials.gov identifier: NCT01687881, 11 September 2012.

Keywords: Cervicogenic headache; Chiropractic; Headache; RCT; Randomized controlled trial; Spinal manipulative therapy.

Figures

Fig. 1
Fig. 1
a–d Mean changes from baseline to follow-up for primary and secondary end-points

References

    1. Sjaastad O, Fredriksen TA, Pfaffenrath V. Cervicogenic headache: diagnostic criteria. The cervicogenic headache international study group. Headache. 1998;38:442–445. doi: 10.1046/j.1526-4610.1998.3806442.x.
    1. ICHD: Headache Classification Subcommittee of the International Headache Society The international classification of headache disorders, 3rd edition (beta version) Cephalalgia. 2013;33:629–808. doi: 10.1177/0333102413485658.
    1. Nilsson N. The prevalence of cervicogenic headache in a random population sample of 20–59 year olds. Spine (Phila Pa 1976) 1995;20:1884–1888. doi: 10.1097/00007632-199509000-00008.
    1. Pareira Monteriro J. Epidemiologic e clinico de uma populacäo urbana. Porto: University of Porto, Cefaleia; 1995.
    1. ICHD: Headache Classification Subcommittee of the International Headache Society The international classification of headache disorders, 2nd edition. Cephalalgia. 2004;24(Suppl 1):9–160.
    1. Sjaastad O, Bakketeig LS. Prevalence of cervicogenic headache: Vaga study of headache epidemiology. Acta Neurol Scand. 2008;117:173–180. doi: 10.1111/j.1600-0404.2007.00962.x.
    1. Knackstedt H, Bansevicius D, Aaseth K, Grande RB, Lundqvist C, Russell MB. Cervicogenic headache in the general population: the Akershus study of chronic headache. Cephalalgia. 2010;30:1468–1476. doi: 10.1177/0333102410368442.
    1. Fernandez-de-las-Penas C, Alonso-Blanco C, San-Roman J, Miangolarra-Page JC. Methodological quality of randomized controlled trials of spinal manipulation and mobilization in tension-type headache, migraine, and cervicogenic headache. J Orthop Sports Phys Ther. 2006;36:160–169. doi: 10.2519/jospt.2006.36.3.160.
    1. Chaibi A, Russell MB. Manual therapies for cervicogenic headache: a systematic review. J Headache Pain. 2012;13:351–359. doi: 10.1007/s10194-012-0436-7.
    1. Tfelt-Hansen P, Block G, Dahlof C, Diener HC, Ferrari MD, Goadsby PJ, Guidetti V, Jones B, Lipton RB, Massiou H, International Headache Society Clinical Trial Subcommittee et al. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia. 2000;20:765–786. doi: 10.1046/j.1468-2982.2000.00117.x.
    1. Silberstein S, Tfelt-Hansen P, Dodick DW, Limmroth V, Lipton RB, Pascual J, Wang SJ. Task Force of the International Headache Society Clinical Trial Subcommittee. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia. 2008;28:484–495. doi: 10.1111/j.1468-2982.2008.01555.x.
    1. Tfelt-Hansen P, Bjarnason NH, Dahlof C, Derry S, Loder E, Massiou H. Evaluation and registration of adverse events in clinical drug trials in migraine. Cephalalgia. 2008;28:683–688. doi: 10.1111/j.1468-2982.2008.01600.x.
    1. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. doi: 10.1136/bmj.c869.
    1. Chaibi A, Benth JS, Tuchin PJ, Russell MB. Chiropractic spinal manipulative therapy for cervicogenic headache: a study protocol of a single-blinded placebo-controlled randomized clinical trial. Springerplus. 2015;4:779. doi: 10.1186/s40064-015-1567-5.
    1. Cooperstein R. Gonstead chiropractic technique (GCT) J Chiropr Med. 2003;2:16–24. doi: 10.1016/S0899-3467(07)60069-X.
    1. Chaibi A, Benth JS, Russell MB. Validation of placebo in a manual therapy randomized controlled trial. Sci Rep. 2015;5:11774. doi: 10.1038/srep11774.
    1. Russell MB, Rasmussen BK, Brennum J, Iversen HK, Jensen RA, Olesen J. Presentation of a new instrument: the diagnostic headache diary. Cephalalgia. 1992;12:369–374. doi: 10.1111/j.1468-2982.1992.00369.x.
    1. Silberstein SD, Neto W, Schmitt J, Jacobs D. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol. 2004;61:490–495. doi: 10.1001/archneur.61.4.490.
    1. Aaseth K, Grande RB, Benth JS, Lundqvist C, Russell MB. 3-year follow-up of secondary chronic headaches: the Akershus study of chronic headache. Eur J Pain. 2011;15:186–192. doi: 10.1016/j.ejpain.2010.06.005.
    1. Fernandez-de-las-Penas C, Alonso-Blanco C, Cuadrado ML, Pareja JA. Spinal manipulative therapy in the management of cervicogenic headache. Headache. 2005;45:1260–1263. doi: 10.1111/j.1526-4610.2005.00253_1.x.
    1. Nilsson N. A randomized controlled trial of the effect of spinal manipulation in the treatment of cervicogenic headache. J Manip Physiol Ther. 1995;18:435–440.
    1. Jull G, Trott P, Potter H, Zito G, Niere K, Shirley D, Emberson J, Marschner I, Richardson C. A randomized controlled trial of exercise and manipulative therapy for cervicogenic headache. Spine (Phila Pa 1976) 2002;27:1835–1843. doi: 10.1097/00007632-200209010-00004.
    1. Haas M, Groupp E, Aickin M, Fairweather A, Ganger B, Attwood M, Cummins C, Baffes L. Dose response for chiropractic care of chronic cervicogenic headache and associated neck pain: a randomized pilot study. J Manip Physiol Ther. 2004;27:547–553. doi: 10.1016/j.jmpt.2004.10.007.
    1. Haas M, Spegman A, Peterson D, Aickin M, Vavrek D. Dose response and efficacy of spinal manipulation for chronic cervicogenic headache: a pilot randomized controlled trial. Spine J. 2010;10:117–128. doi: 10.1016/j.spinee.2009.09.002.
    1. Speciali JG, Peres M, Bigal ME. Migraine treatment and placebo effect. Expert Rev Neurother. 2010;10:413–419. doi: 10.1586/ern.10.8.
    1. de Groot FM, Voogt-Bode A, Passchier J, Berger MY, Koes BW, Verhagen AP. Headache: the placebo effects in the control groups in randomized clinical trials; an analysis of systematic reviews. J Manip Physiol Ther. 2011;34:297–305. doi: 10.1016/j.jmpt.2011.04.007.
    1. Chaibi A, Benth JS, Tuchin P, Russell MB. Chiropractic spinal manipulative therapy for migraine: a three-armed, single-blinded, placebo, randomized controlled trial. Eur J Neurol. 2017;24:143–153. doi: 10.1111/ene.13166.
    1. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet. 2010;375:686–695. doi: 10.1016/S0140-6736(09)61706-2.
    1. Chaibi A, Benth JS, Tuchin P, Russell MB. Adverse events in a chiropractic spinal manipulative therapy single-blinded, placebo, randomized controlled trial for migraineurs. Musculoskelet Sci Pract. 2017;29:66–71. doi: 10.1016/j.msksp.2017.03.003.
    1. Mitsikostas DD, Mantonakis LI, Chalarakis NG. Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches. Cephalalgia. 2011;31:550–561. doi: 10.1177/0333102410391485.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren